Serial assays of qualitative (multiplex and nested) and quantitative PCR were carried out for
detecting and estimating the level of BCR-ABL transcripts in 39 CML patients following bone …

Quantitative competitive RT-PCR techniques have been developed to detect BCR-ABL
fusion transcripts in CML but they are hardly reproducible. In this work, we have developed …

We have developed a competitive polymerase chain reaction (PCR) titration assay that
estimates the number of BCR-ABL transcripts in chronic myeloid leukemia patients to …

The polymerase chain reaction (PCR) was used to amplify the bcr/abl transcript as a marker
of minimal residual disease (MRD) in 76 patients with chronic myeloid leukemia (CML) …

We prospectively studied 98 chronic myeloid leukemia (CML) patients after bone marrow
transplantation by competitive polymerase chain reaction to detect and quantify leukemia …

We identified 243 patients with Philadelphia (Ph) chromosome–positive chronic myeloid
leukemia (CML) who had BCR-ABL transcripts monitored by quantitative reverse …

We report here the results of polymerase chain reaction (PCR) for bcr-abl transcript and
clinical details derived from 64 chronic myelogenous leukemia (CML) patients after …

We performed a two-step polymerase chain reaction (PCR) to detect bcr-abl-specific mRNA
in 440 peripheral blood and/or bone marrow samples of 30 chronic myeloid leukemia (CML) …

The monitoring of minimal residual disease (MRD) through low sensitivity real-time (RT)
polymerase chain reaction (PCR) analysis of BCR-ABL transcripts allows early detection of …

BACKGROUND. Chronic myeloid leukemia (CML) is a disease characterized by the
presence of a unique molecular marker, ie the fusion gene bcr-abl and its mRNA and protein …